Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions

Due to the need of early and emergency effective treatments for COVID-19, less attention may have been paid to their safety during the global emergency. In addition, characteristics of drug–drug interaction (DDI)-related adverse drug reactions (ADRs) in COVID-19 patients have not yet been studied in...

Descripción completa

Detalles Bibliográficos
Autores principales: Crescioli, Giada, Brilli, Valentina, Lanzi, Cecilia, Burgalassi, Andrea, Ieri, Alessandra, Bonaiuti, Roberto, Romano, Elias, Innocenti, Rinaldo, Mannaioni, Guido, Vannacci, Alfredo, Lombardi, Niccolò
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755981/
https://www.ncbi.nlm.nih.gov/pubmed/33355896
http://dx.doi.org/10.1007/s11739-020-02586-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755981/
https://www.ncbi.nlm.nih.gov/pubmed/33355896
http://dx.doi.org/10.1007/s11739-020-02586-8

Ejemplares similares